Pathstone Family Office’s Vitamin Shoppe Inc. VSI Stock Holding History

Pathstone Family Office’s Portfolio VSI Stock Details VSI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q2	–	Sell	-14	Closed	–	–	696
2017 Q1	$0	Buy	+14	New	+$299	﹤0.01%	644

Other funds holding VSI

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Carlson Capital Dallas, Texas $318M AUM 27.64% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Fuller & Thaler Asset Management San Mateo, California $29.7B AUM 43.33% 1-Year Est. Return

EAM

Eagle Asset Management St Petersburg, Florida $19.6B AUM 41.58% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Barrow, Hanley, Mewhinney & Strauss Dallas, Texas $30.5B AUM 29.95% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Pathstone Family Office's VSI Position: Q2 2017 in Review

Pathstone Family Office sold out of Vitamin Shoppe Inc. (VSI) in Q2 2017, closing a stake of 14 shares.

Pathstone Family Office first reported a position in VSI in Q1 2017 and held it in 1 quarter. The position peaked at $0 in Q1 2017. 135 funds tracked by Wall St. Rank hold VSI as of Q2 2017.

Pathstone Family Office reported no remaining Vitamin Shoppe Inc. position as of Q2 2017 after selling out during the quarter.
Pathstone Family Office sold 14 Vitamin Shoppe Inc. shares in Q2 2017.
Pathstone Family Office first reported a position in Vitamin Shoppe Inc. in Q1 2017 and held it in 1 quarter.
Pathstone Family Office's Vitamin Shoppe Inc. position peaked at $0 in Q1 2017.
135 funds tracked by Wall St. Rank held Vitamin Shoppe Inc. as of Q2 2017.

Based on Pathstone Family Office's 13F filing for Q2 2017, filed 11 Aug 2017.